UNC0379 is a substrate competitive lysine methyltransferase SETD8 (KMT5A) inhibitor with antineoplastic activity.

Urea J Acid (AMI-1; AMI 1) is a selective inhibitor of Histone Methyltransferase (HMT) with anti-inflammatory activity.

MM-102 TFA (the trifluoroacetic acid salt of MM-102) is a novel, potent, high-affinity peptidomimetic MLL1 inhibitor with IC50 of 0.4 μM in a cell-free assay.

SGC2085, identified from virtual screening approaches, is a novel, potent and selective inhibitor of coactivator associated arginine methyltransferase 1 (CARM1) with an IC50 of 50 nM.

LLY-283 (LLY283) is the first-in-class and selective SAM-competitive inhibitor of PRMT5 (protein arginine methyltransferase 5) with antitumor activity.

CPI-169 (CPI169) is a novel, potent, and selective inhibitor of EZH2 (enhancer of zeste homolog 2) inhibitor with anticancer activity.

Valemetostat tosylate (DS3201; DS3201b; Ezharmia), the tosylate salt of Valemetostat, is an investigational and orally bioavailable dual EZH1/2 inhibitor with potential anticancer activity.

EPZ-031686 (EPZ031686) is a potent, selective and orally bioavailable SMYD3 (Set and Mynd Domain containing 3) inhibitor with potential antitumor activity.

5WKS (ZINC97756584) is a bioactive chemical compound for research use.

Chaetocin, a naturally occurring fungal mycotoxin extracted from Chaetomium, is a novel and non-specific inhibitor of the histone lysine methyltransferase (HMT) G9a with an IC50 of 2.5 μM. It belongs to the class of 3,6-epidithio-diketopiperazines.